5-159319588-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_002187.3(IL12B):​c.698-695G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0188 in 152,322 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.019 ( 47 hom., cov: 32)

Consequence

IL12B
NM_002187.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.92

Publications

5 publications found
Variant links:
Genes affected
IL12B (HGNC:5970): (interleukin 12B) This gene encodes a subunit of interleukin 12, a cytokine that acts on T and natural killer cells, and has a broad array of biological activities. Interleukin 12 is a disulfide-linked heterodimer composed of the 40 kD cytokine receptor like subunit encoded by this gene, and a 35 kD subunit encoded by IL12A. This cytokine is expressed by activated macrophages that serve as an essential inducer of Th1 cells development. This cytokine has been found to be important for sustaining a sufficient number of memory/effector Th1 cells to mediate long-term protection to an intracellular pathogen. Overexpression of this gene was observed in the central nervous system of patients with multiple sclerosis (MS), suggesting a role of this cytokine in the pathogenesis of the disease. The promoter polymorphism of this gene has been reported to be associated with the severity of atopic and non-atopic asthma in children. [provided by RefSeq, Jul 2008]
IL12B Gene-Disease associations (from GenCC):
  • Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0188 (2861/152322) while in subpopulation NFE AF = 0.031 (2110/68022). AF 95% confidence interval is 0.0299. There are 47 homozygotes in GnomAd4. There are 1299 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 47 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002187.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL12B
NM_002187.3
MANE Select
c.698-695G>A
intron
N/ANP_002178.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL12B
ENST00000231228.3
TSL:1 MANE Select
c.698-695G>A
intron
N/AENSP00000231228.2P29460
IL12B
ENST00000696750.1
c.68-695G>A
intron
N/AENSP00000512849.1A0A8Q3WML5
IL12B-AS1
ENST00000765009.1
n.694C>T
non_coding_transcript_exon
Exon 3 of 3

Frequencies

GnomAD3 genomes
AF:
0.0188
AC:
2860
AN:
152204
Hom.:
47
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00521
Gnomad AMI
AF:
0.0965
Gnomad AMR
AF:
0.0199
Gnomad ASJ
AF:
0.00835
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00600
Gnomad FIN
AF:
0.00537
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0310
Gnomad OTH
AF:
0.0129
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0188
AC:
2861
AN:
152322
Hom.:
47
Cov.:
32
AF XY:
0.0174
AC XY:
1299
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00520
AC:
216
AN:
41568
American (AMR)
AF:
0.0199
AC:
304
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00835
AC:
29
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00621
AC:
30
AN:
4830
European-Finnish (FIN)
AF:
0.00537
AC:
57
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0310
AC:
2110
AN:
68022
Other (OTH)
AF:
0.0128
AC:
27
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
153
305
458
610
763
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0252
Hom.:
81
Bravo
AF:
0.0191
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.021
DANN
Benign
0.50
PhyloP100
-1.9
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3213102; hg19: chr5-158746596; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.